TTK Healthcare
929.10
+2.60(+0.28%)
Market Cap₹1,312.85 Cr
PE Ratio21.77
IndustryDiversified
Company Performance:
1D+0.28%
1M-7.45%
6M-18.42%
1Y-23.88%
5Y+62.46%
View Company Insightsright
More news about TTK Healthcare
22Dec 25
TTK Healthcare Appoints V Sundaresan as Additional Independent Director
TTK Healthcare Limited announced the appointment of V Sundaresan as Additional Independent Director following a board meeting on December 22, 2025. The appointment requires shareholder approval through postal ballot, with voting scheduled from December 25, 2025 to January 24, 2026. Sundaresan brings nearly four decades of financial leadership experience, having served as CFO of TTK Prestige Ltd. and held senior positions at General Electric and other organizations.
 no imag found
17Oct 25
TTK Healthcare Reports 18.6% Rise in Q2 Net Profit Despite EBITDA Margin Compression
TTK Healthcare Limited posted mixed Q2 FY2026 results. Net profit increased by 18.60% to ₹204.00 crore, while revenue grew marginally by 1.00% to ₹2,000.00 crore. However, EBITDA declined by 35.20% to ₹53.30 crore, and EBITDA margin compressed by 153 bps to 2.62%. The company demonstrated resilience in bottom-line growth despite operational challenges, suggesting effective cost management in other areas.
 no imag found
18Sept 25
TTK Healthcare Completes Share Transmission from Deceased Promoters to Legal Heirs
TTK Healthcare Limited has successfully completed the share transmission process from deceased promoters Late Thiruvallur Thattai Jagannathan and Late Thiruvallur Thattai Venkatesh to their legal heirs. The transmission involves 7,73,298 shares being distributed among three beneficiaries, with regulatory compliance under SEBI LODR ensuring updated promoter group classification.
 no imag found
26Aug 25
TTK Healthcare Faces ₹2.27 Crore Interest Withdrawal, Plans to Appeal Income Tax Orders
TTK Healthcare Limited has received income tax orders for assessment years 2016-17 and 2017-18, totaling ₹2,27,31,162. The orders involve withdrawal of interest granted under Section 244A and charging of interest under Section 234D. The company plans to appeal against these orders through appropriate legal channels, expressing confidence in obtaining relief.
 no imag found
04Aug 25
TTK Healthcare Reports Revenue Growth and 61% Decline in Q1 EBITDA
TTK Healthcare Limited reported mixed Q1 results with revenue increasing by 8.91% to ₹2,264.30 crore. However, net profit declined by 58.82% to ₹130.00 crore, and EBITDA fell by 60.87% to ₹27.00 crore. The Consumer Products segment was the largest revenue contributor, while Protective Devices showed the highest profitability. The company's total assets stood at ₹13,108.66 crore with total liabilities of ₹2,322.46 crore.
 no imag found
25Jul 25
TTK Healthcare Reports 6% Revenue Growth, Maintains Rs 10 Dividend at 67th AGM
TTK Healthcare's 67th AGM revealed a 6% increase in revenue to Rs 801.49 crores and a significant jump in pre-tax profit to Rs 108.33 crores, including one-time income. EPS improved to Rs 57.79. The company maintained its dividend at Rs 10 per share. Performance varied across segments, with some showing growth while others faced challenges. The company has a strong cash balance of Rs 900 crores and expressed a positive outlook for the future, focusing on strategic initiatives across its diverse business portfolio.
 no imag found
23May 25
TTK Healthcare Reports Mixed Q4 Results, Declares ₹10 Dividend
TTK Healthcare's Q4 results show revenue growth to ₹1.90 billion, up 5.56% year-over-year. However, profitability declined with EBITDA falling to ₹120.00 million and net profit decreasing to ₹161.00 million. Despite challenges, the company declared a dividend of ₹10.00 per share.
 no imag found
02May 25
TTK Healthcare Faces Setback as USAID Cancels Condom Procurement Agreement
TTK Healthcare announced the cancellation of its agreement with Chemonics due to USAID's decision to stop condom procurement from the company. This has left TTK Healthcare with unsold inventory worth ₹58.60 million. The company plans to explore remedies, including potential legal action, to mitigate the impact of this contract cancellation.
 no imag found
TTK Healthcare
929.10
+2.60
(+0.28%)
1 Year Returns:-23.88%
Industry Peers
3M India
36,145.00
(-2.03%)
Godrej Industries
1,034.35
(+0.80%)
DCM Shriram Consolidated
1,091.90
(+0.91%)
Swan Corp
405.75
(+0.43%)
Sindhu Trade Links
25.41
(+1.36%)
Balmer Lawrie & Co
180.43
(+1.09%)
TTK Healthcare
929.10
(+0.28%)
Dhunseri Ventures
247.65
(+1.10%)
Empire Industries
897.40
(+0.32%)